Incidence and Virulence Determinants of Verocytotoxin-Producing Escherichia coli Infections in the Brussels-Capital Region, Belgium, in 2008-2010

Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011

(2017) F Scheutz et al.   Eurosurveillance

Point-Counterpoint: Should All Stools Be Screened for Shiga Toxin-Producing Escherichia coli?POINTCOUNTERPOINTSUMMARY

(2011) Mario J. Marcon et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study

(2011) Martina Bielaszewska et al.   LANCET INFECTIOUS DISEASES

Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany

(2011) Christina Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antimicrobial Resistance Testing of Verocytotoxin-Producing Escherichia coli and First Description of TEM-52 Extended-Spectrum  -Lactamase in Serogroup O26

(2010) G. Buvens et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Shiga toxin-producing Escherichia coli O157 associated with human infections in Switzerland, 2000–2009

(2010) U. KÄPPELI et al.   EPIDEMIOLOGY AND INFECTION

Prevalence of subtilase cytotoxin in verocytotoxin-producing Escherichia coli isolated from humans and raw meats in Belgium

(2010) G. Buvens et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Virulence Profiling and Quantification of Verocytotoxin-Producing Escherichia coli O145:H28 and O26:H11 Isolated During an Ice Cream–Related Hemolytic Uremic Syndrome Outbreak

(2010) Glenn Buvens et al.   Foodborne Pathogens and Disease

Economic Costs of Shiga Toxin–Producing Escherichia coli Infection in Australia

(2010) Michelle McPherson et al.   Foodborne Pathogens and Disease

Characteristics of O157 versus Non‐O157 Shiga Toxin–ProducingEscherichia coliInfections in Minnesota, 2000–2006

(2009) Erin B. Hedican et al.   CLINICAL INFECTIOUS DISEASES

Sab, a Novel Autotransporter of Locus of Enterocyte Effacement-Negative Shiga-Toxigenic Escherichia coli O113:H21, Contributes to Adherence and Biofilm Formation

(2009) S. Herold et al.   INFECTION AND IMMUNITY

Escherichia coli encoding Shiga toxin 2f as an emerging human pathogen

(2009) Rita Prager et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhoea in Argentina

(2009) M. A. Rivero et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands

(2008) Y.T.H.P. van Duynhoven et al.   CLINICAL MICROBIOLOGY AND INFECTION